SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Nectar Lifesciences
Nectar Lifesciences
BSE: 532649|NSE: NECLIFE|ISIN: INE023H01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 06, 17:00
34.65
1.5 (4.52%)
VOLUME 200,857
LIVE
NSE
Jul 06, 17:00
34.70
1.55 (4.68%)
VOLUME 560,662
Business News on Nectar Lifesciences
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Will make $10-20 mn annually on Brazil drug nod: Nectar

12.40 pm | 18 May 2015 |  Source: CNBC-TV18

Dinesh Dua, chief executive officer, Nectar Life Sciences, expects the company’s margin to be close to 20 percent. ...

1
Quick Links for Nectar Lifesciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.